The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations

For patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer, the relationship between the dose or duration of treatment with tyrosine kinase inhibitor (TKI) and overall survival remains unclear. Here, we analyzed clinical data of 39 patients who were diagnosed with EGFR m...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hidekazu, Hirashima, Tomonori, Okamoto, Norio, Yamadori, Tadahiro, Tamiya, Motohiro, Morishita, Naoko, Shiroyama, Takayuki, Otsuka, Tomoyuki, Kitai, Kanako, Kawase, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845597/
https://www.ncbi.nlm.nih.gov/pubmed/23237215
http://dx.doi.org/10.5732/cjc.012.10160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845597/
https://www.ncbi.nlm.nih.gov/pubmed/23237215
http://dx.doi.org/10.5732/cjc.012.10160

Ejemplares similares